Status: current, Defined. Date: 31-May 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2382091000168117 | Tobramycin (WKT) (tobramycin 300 mg / 5 mL) inhalation solution, 56 x 5 mL ampoules (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2382101000168110 | Tobramycin (WKT) 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tobramycin (WKT) 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules | Is a | Tobramycin (WKT) 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules | true | Inferred relationship | Some | ||
| Tobramycin (WKT) 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Tobramycin (WKT) 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules | has TPUU | Tobramycin (WKT) 300 mg/5 mL inhalation solution, 5 mL ampoule | true | Inferred relationship | Some | 1 | |
| Tobramycin (WKT) 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules | has container type | ampoule | true | Inferred relationship | Some | ||
| Tobramycin (WKT) 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules | has TP | Tobramycin (WKT) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR